Player size: small large

ISHLTv_06 - When a Single Ventricle Support is Not Enough!

Sep 30, 2020 7:00am ‐ Sep 30, 2020 8:30am

Members: Free

Overview
Comments

An ISHLT 2020 Symposium Presentation

Session Description:
Biventricular failure is associated with high in-hospital mortality. The aim of this session is to explore the clinical utility of extra- and intracorporeal as well as percutaneous MCS for patients persisting biventricular failure. In this session the currently available devices for treating shock and heart failure and a look ahead within this developing field, including new devices and novel indications for established technology should be presented.

Moderators:
Emily K. Granger, MBBS. (Hons) FRACP, St. Vincent’s Hospital, Darlinghurst, Sydney, Australia
Yaron Barac, MD, PhD, Rabin Medical Center, Petah Tikva, Israel

Welcome & Recognition of ISHLT/OH Frazier Award in MCS Translational Research, sponsored by Medtronic
ISHLT President Joseph Rogers, MD, Duke University Medical Center, Durham, NC, USA

Jordan R.H. Hoffman, MD, Assistant Professor in Cardiac Surgery at Vanderbilt University School of Medicine in Nashville, TN., receives the O.H. Frazier Award in MCS Translational Research sponsored by Medtronic. The $65,000 award will allow Dr. Hoffman to study complications that arise in some heart failure patients who rely on Left Ventricular Assist Devices (LVADs) for cardiac support.

Defining Biventricular Heart Failure
Cesar I. Guerrero-Miranda, MD. Baylor University Medical Center, Dallas, TX, USA

This talk will review current understanding of the definition of RV failure utilizing a combination of clinical assessment, invasive hemodynamic data and imaging, including 3D volumetric assessment of RV and TV and RV strain imaging.

Variety of Temporary Biventricular Support
Jamila Kremer, MD. University Hospital Heidelberg, Heidelberg, Germany

This talk will show possible combinations biventricular Impella vs ECMO vs Temp Bi-VAD (Levitronix). The presentation will include appropriate candidacy, indication, complications, advantage, disadvantages.

When Durable LVAD Alone is Not Enough: Short-Term Right Ventricular Mechanical Support in LVAD Patients
Sarah E. Scheuer, MD. St Vincent's Hospital, Sydney, Paddington, Australia

This talk will review current state-of-art available RV temporary mechanical support, including but not limited to Protec Duo, RP Impella, TamdenHeart, and CentriMag, in the management of right ventricular cardiogenic shock.

Paracorporeal Devices Still Exist: Continuous Flow VADs in Combination with Paracorporeal Devices
Jan D. Schmitto, MD, PhD, MBA, FCCP, FRCS. Hannover Medical School, Hannover, Germany

This talk will review the insertion and management of surgically implanted paracorporeal devices in combinations with continuous flow pumps and the techniques to ensure prolonged support, minimize complications and discuss appropriate candidacy, advantages and disadvantages.

Which Device in Which Configuration for Biventricular Support: BiVAD vs Total Artificial Heart? How, Which and When?
Ivan Knezevic, MD. Univ Clinical Centre, Ljubljana, Slovenia

The speaker will discuss the total artificial heart including the Syncardia and Carmat devices.

Do It Both Ways: BiVAD vs. Bivad in a TAH Configuration
Evgenij V. Potapov, MD, PhD. Deutsches Herzzentrum, Berlin, Germany

This presentation will highlight the possibility of long-term biventricular support by continuous-flow BIVADs. After off-label use of 2 HeartWare VAD, now the use of 2 HeartMate 3 pumps has been described. The present should give some more insight into this new developing field of MCS support in biventricular failure.

Live Q & A segment with all speakers

ISHLT Mechanical Circulatory Support Interdisciplinary Network Update
Diyar Saeed, MD, PhD, Leipzig Heart Center, Leipzig, Germany
Chair, ISHLT Mechanical Circulatory Support Interdisciplinary Network Steering Committee

ISHLT Announcements
Greg Schultz, CAE, Chief Executive Officer, ISHLT, Addison, TX, USA

Speaker(s):

Emily Granger, MBBS. (Hons) FRACS, Cardiothoracic Surgeon, Transplant Surgeon Darlinghurst Sydney, Australia, St. Vincent's Hospital
Yaron Barac, MD, PhD, Director, Heart and Lung Transplant and MCS Program Division of Cardiovascular and Thoracic Surgery Petach-Tikva, Israel, Rabin Medical Center
Joseph Rogers, MD, Chief Medical Officer Professor of Medicine – Cardiology Durham, NC, USA, Duke University Health System
Cesar Guerrero-Miranda, MD, FACC, Advanced Heart Failure and Transplant Cardiologist Clinical Assistant Professor, Texas A&M Center Center for Advanced Heart and Lung Disease Dallas, TX, USA, Baylor University Medical Center
Jamila Kremer, MD, Heidelberg, Germany, University Hospital Heidelberg
Sarah E. Scheuer, MD, Cardiothoracic Research Fellow PhD Candidate Sydney, Australia, St. Vincent's Hospital
Jan Schmitto, MD, PhD, MBA, FCCP, FRCS, Hannover, Germany, Hannover Medical School
Ivan Knezevic, MD, Director, Transplantation Centre Ljubljana, Slovenia, University Clinical Centre
Evgenij V. Potapov, MD, PhD, Senior Cardiac Surgeon Head Ventricular Assist Device Team Department of Cardiothoracic and Vascular Surgery Berlin, Germany, Deutsches Herzzentrum Berlin
Diyar Saeed, MD, PhD, Leipzig, Germany, Leipzig Heart Center
Greg Schultz, CEO, Addison, TX, USA, International Society for Heart and Lung Transplantation

You must be logged in and own this session in order to post comments.